论文部分内容阅读
莱美药业新入选I66的主要原因是技术指标重新符合I66入选要求。最新综合目标价为25.63元,12个月涨升空间达到17.14%。近一周内兴业证券将其2011年最新盈利预测由0.38元调高至0.50元。
The main reason for the new listing of the Iomera I66 is the technical indicators re-meet I66 inclusion requirements. The latest consolidated target price of 25.63 yuan, up 12 space rose to 17.14%. Nearly a week, Societe Generale raised its 2011 earnings forecast from 0.38 yuan to 0.50 yuan.